Scientific Assoc. VP
Merck & Co., Inc.
West Point, Pennsylvania, United States
Julie A. Stone, Ph.D., is a Scientific Associate Vice President in Quantitative Pharmacology and Pharmacometrics at Merck & Co., Inc. Julie joined Merck in 1995 following graduate studies in biomedical engineering at the University of Pennsylvania and postdoctoral research in pharmacokinetic modeling at Hoffmann-La Roche. At Merck, she has provided pharmacology and pharmacometrics support for a variety of programs, including 13 approved drugs. As a senior scientist on the research ladder, she divides time between individual scientific contributions in areas including Alzheimers Disease, osteoporosis, and antivirals with setting and overseeing wider scientific strategy of quantitative pharmacology and pharmacometrics application in drug development. In this role, she works to bring the power that the sophisticated quantitative tools of modeling offer together with effective, impact focused communication to enable better informed decisions and regulatory interactions.
Disclosure(s): Merck & Co., Inc.: Employment (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing)
Enabling Progress Against Alzheimer's Disease: Power of Diverse Pharmacometrics Approaches
Monday, November 11, 2024
3:15 PM – 4:45 PM MST
Monday, November 11, 2024
4:15 PM – 4:45 PM MST
